| Literature DB >> 33578670 |
Emile S Massima Mouele1,2, Jimoh O Tijani1,3, Kassim O Badmus1, Omoniyi Pereao1, Omotola Babajide1,4, Cheng Zhang5, Tao Shao5, Eduard Sosnin6, Victor Tarasenko6, Ojo O Fatoba1, Katri Laatikainen2, Leslie F Petrik1.
Abstract
Persistent pharmaceutical pollutants (PPPs) have been identified as potential endocrine disruptors that mimic growth hormones when consumed at nanogram per litre to microgram per litre concentrations. Their occurrence in potable water remains a great threat to human health. Different conventional technologies developed for their removal from wastewater have failed to achieve complete mineralisation. Advanced oxidation technologies such as dielectric barrier discharges (DBDs) based on free radical mechanisms have been identified to completely decompose PPPs. Due to the existence of pharmaceuticals as mixtures in wastewater and the recalcitrance of their degradation intermediate by-products, no single advanced oxidation technology has been able to eliminate pharmaceutical xenobiotics. This review paper provides an update on the sources, occurrence, and types of pharmaceuticals in wastewater by emphasising different DBD configurations previously and currently utilised for pharmaceuticals degradation under different experimental conditions. The performance of the DBD geometries was evaluated considering various factors including treatment time, initial concentration, half-life time, degradation efficiency and the energy yield (G50) required to degrade half of the pollutant concentration. The review showed that the efficacy of the DBD systems on the removal of pharmaceutical compounds depends not only on these parameters but also on the nature/type of the pollutant.Entities:
Keywords: advanced oxidation technologies; chemicals/contaminants of emerging concern (CEC); dielectric barrier discharge; excilamp; pharmaceutical residues; wastewater; water
Year: 2021 PMID: 33578670 PMCID: PMC7916394 DOI: 10.3390/ijerph18041683
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390